Fusion Pharmaceuticals Inc. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Collaboration Agreements (5 contracts)
- Development Agreements (2)
- Indemnification Agreements (2)
- Amendment No. 3 to Collaboration Agreement, dated August 12, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Amendment No. 2 to Collaboration Agreement, dated July 27, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Amendment No. 1 to Collaboration Agreement, dated June 28, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Collaboration Agreement, dated December 10, 2020, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company (Filed With SEC on November 9, 2021)
- Strategic Collaboration Agreement by and between Fusion Pharmaceuticals Inc. and AstraZeneca UK Limited, dated October 30, 2020 (Filed With SEC on November 2, 2020)
- Form of Director Indemnification Agreement (Filed With SEC on June 22, 2020)
- Form of Officer Indemnification Agreement (Filed With SEC on June 22, 2020)
- Supply Agreement, dated as of January 17, 2019, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant (Filed With SEC on June 5, 2020)
- Master Services Agreement, dated as of February 22, 2017, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant (Filed With SEC on June 5, 2020)
